Characteristics associated with the use of complementary health approaches among long-term cancer survivors
Characteristics associated with the use of complementary health approaches among long-term cancer survivors
复制标题
DOI：
10.1007/s00520-013-2040-z
复制
发表时间：
2014-04-01
影响因子：
3.1
通讯作者：
Hamilton, Ann S.
中科院分区：
文献类型：
--
作者：
Sohl, Stephanie J.;Weaver, Kathryn E.;Hamilton, Ann S.
本研究的目的是确定使用补充健康方法（CHA）的长期成年癌症幸存者的患病率和特征。参与者完成了幸存者随访护理使用（FOCUS）调查，这是一项针对长期癌症幸存者的横断面调查。评估了CHA的使用情况和使用原因。应用多变量逻辑回归模型来确定补充和替代医学医疗保健模型中描述的易感性、使能性和需求特征是否与过去一年中CHA的使用相关。（N = 1，666）主要为女性（62%）和老年人（平均年龄= 69.5），患有乳腺癌、前列腺癌、结直肠癌、卵巢癌和子宫内膜癌。33%的幸存者在过去一年中使用了CHA。使用CHA的常见原因是缓解压力（28%），治疗或预防癌症（21%），缓解癌症相关症状（18%）和处理其他疾病（18%）。易患病（即，更高的乐观）和需要因素（即，经历过癌症相关症状，曾经有过抑郁/焦虑）与CHA显著相关（p值<0.05）。有利因素（即，癌症幸存者继续报告在初次诊断后5年以上最近使用CHA的高流行率。医疗保健提供者应该意识到CHA在长期癌症幸存者亚组中的使用增加，以指导安全和最佳使用。
This study aims to identify the prevalence and characteristics of long-term adult cancer survivors who use complementary health approaches (CHA).Participants completed the Follow-up Care Use Among Survivors (FOCUS) Survey, a cross-sectional investigation of long-term cancer survivors. The use of CHA and reasons for use were assessed. A multivariable logistic regression model was applied to identify if predisposing, enabling, and need characteristics described in the Complementary and Alternative Medicine Healthcare Model were associated with CHA use in the past year.Long-term cancer survivors in the study (N = 1,666) were predominately female (62 %) and older (mean age = 69.5), with breast, prostate, colorectal, ovarian, and endometrial cancers. Thirty-three percent of survivors used CHA in the past year. Common reasons for CHA use were to relieve stress (28 %), treat or prevent cancer (21 %), relieve cancer-related symptoms (18 %), and deal with another condition (18 %). Predisposing (i.e., higher optimism) and need factors (i.e., experienced cancer-related symptoms, ever had depression/anxiety) were significantly associated with CHA (p-values < .05). Enabling factors (i.e., insurance coverage, financial resources) were not.Cancer survivors continue to report a high prevalence of recent CHA use more than 5 years after initial diagnosis. Healthcare providers should be aware of increased use of CHA among subgroups of long-term cancer survivors in order to guide safe and optimal use.